Table 1 Demographic and baseline characteristics of 120 patients with hepatocellular carcinoma
Factors | Value | Percent |
|---|---|---|
Demographic characteristics | Â | Â |
Age | 50.1 ± 11.9 |  |
Gender (male/female) | 108/12 | 90.0/10.0 |
Tumor characteristics | Â | Â |
Maximum tumor diameter | 6.9 ± 4.2 |  |
Tumor encapsulation | 33 | 27.5 |
Tumor number (multiple)* | 15 | 12.5 |
Microvascular invasion | 65 | 54.2 |
Major vascular invasion | 6 | 5.0 |
Edmondson grade | Â | Â |
Low (I/II) | 90 | 75.0 |
High (III/IV) | 30 | 25.0 |
TNM stage | Â | Â |
I/II | 92 | 76.7 |
III | 28 | 23.3 |
Histology of chronic liver disease | Â | Â |
Necroinflammation grade (score) | Â | Â |
No (0) | 0 | 0.0 |
Minimal (1–4) | 6 | 5.0 |
Mild (5–8) | 38 | 31.7 |
Moderate (9–12) | 57 | 47.5 |
Marked (13–18) | 19 | 15.8 |
Fibrosis stage | Â | Â |
0 | 4 | 3.3 |
1-4 | 67 | 55.8 |
5-6 | 49 | 40.9 |
Laboratory values | Â | Â |
AFP (ng/mL) | 351.0 ± 414.1 (1.7-1000.0) |  |
CEA (ng/mL) | 4.3 ± 7.1 (0.0-58.2) |  |
CA19-9 (U/mL) | 15.8 ± 14.4 (0.0-120.8) |  |
ALT (U/L) | 54.6 ± 37.2 (9.8-234.9) |  |
AST (IU/L) | 39.5 ± 19.4 (2.0-108.3) |  |